Insurance Companies as LPs: GP Fundraising Guide 2026

Insurance Companies as LPs: GP Fundraising Guide 2026#

Insurance companies manage $30 trillion in investable assets globally, yet most GPs fail to understand the regulatory capital frameworks, accounting regimes, and liability structures that make insurers a fundamentally different LP category from pension funds, endowments, or family offices.

The Insurance LP Landscape: A $30 Trillion Opportunity#

The global insurance industry is not monolithic. It comprises three distinct sub-sectors—life insurers, property-and-casualty (P&C) carriers, and reinsurers—each with different liability profiles, regulatory constraints, and investment behaviors. Together, they represent the largest single pool of institutional capital that is structurally under-allocated to alternatives relative to other LP categories.

Total Addressable Market#

According to the International Association of Insurance Supervisors (IAIS), global insurance premiums reached $6.8 trillion in 2025, with total assets under management exceeding $30 trillion. The United States accounts for approximately $8.5 trillion of this, Europe $7.2 trillion, Asia-Pacific $10.1 trillion, and the rest of the world $4.2 trillion.

The allocation to alternatives varies dramatically by region and insurer type:

The opportunity is not in the average—it is in the tail. The top 5% of insurance companies by alternatives allocation commit 30-50% of their portfolios to private markets. These are the targets for GPs who understand the regulatory and accounting mechanics that constrain the other 95%.

Why Insurance Companies Are Different#

Insurance companies invest to match or exceed the cost of their liabilities—policyholder claims, annuity obligations, and reserve requirements. This is fundamentally different from pension funds, which invest to fund long-dated retirement obligations, or endowments, which invest to support perpetual institutional missions.

An insurer's investment portfolio is not an asset allocation exercise—it is a balance sheet management exercise. Every allocation decision is filtered through its impact on:

1. Regulatory capital (risk-based capital in the US, Solvency II in Europe)
2. Statutory accounting (SAP vs. GAAP)
3. Rating agency assessment (AMB Best, S&P, Moody's, Fitch)
4. Book value volatility
5. Liability duration matching

A pension fund evaluates a private equity commitment primarily on risk-adjusted returns. An insurance company evaluates that same commitment on risk-adjusted returns, the risk-based capital charge it triggers, how it appears on the statutory balance sheet, the volatility it introduces to book value, and whether the rating agency will view the allocation favorably.

GPs who approach insurance companies with a pension-style pitch—emphasizing IRR, TVPI, and DPI—without addressing capital treatment and accounting will not advance past the first meeting.

Regulatory Frameworks: The Invisible Hand Shaping Insurance Allocations#

Regulatory capital frameworks are the single most important factor determining insurance company investment behavior. They are also the most poorly understood by GPs.

United States: Risk-Based Capital (RBC)#

The US insurance regulatory system is state-based, with the National Association of Insurance Commissioners (NAIC) setting model laws that states adopt. The key framework is Risk-Based Capital (RBC), which requires insurers to hold capital proportional to the riskiness of their assets and liabilities.

RBC charges vary dramatically by asset class:

The 30% RBC charge on direct private equity means a life insurer must hold $30 of capital for every $100 invested in private equity. This is punitive compared to the 0.3% charge on US Treasuries.

However, the NAIC has been gradually modernizing RBC treatment for alternatives. In 2023, the NAIC adopted a new methodology for private equity fund investments that reduced the charge from 30% to 15-22.5% for diversified funds. In 2024, it extended preferential treatment to private credit funds with senior secured lending strategies. In 2025, it proposed similar treatment for infrastructure debt funds.

These changes are incremental but significant. They are the primary reason US insurance allocations to private credit have grown from 5% of portfolios in 2020 to an estimated 11% in 2025, and why private equity allocations have remained relatively flat at 3-4%.

Europe: Solvency II#

Solvency II, effective since 2016, is a more principles-based but equally capital-intensive framework. It uses a Standard Formula for calculating capital requirements, though larger insurers can use Internal Models.

Solvency II capital charges are even more punitive than US RBC:

The 39% charge on private equity under Solvency II is the highest among major regulatory regimes. This has driven European insurers toward private credit and infrastructure, where capital charges are lower.

The Solvency II review, expected to be implemented in 2026-2027, proposes reducing the private equity charge to 30% and creating a new "long-term equity" category with a 22% charge for investments held for more than five years. This would be a significant catalyst for European insurance PE allocations.

Asia: Varying Regimes#

Asia lacks a uniform regulatory framework. Key markets include:

Japan: The Financial Services Agency (FSA) uses a Solvency Margin Ratio similar to Solvency I. Capital charges for alternatives are high—40% for private equity—but the FSA has been gradually reducing charges for infrastructure and real estate.

China: The China Banking and Insurance Regulatory Commission (CBIRC) caps insurance allocations to private equity at 5% of total assets. This limit has been binding for the largest Chinese insurers, which have grown their alternatives allocations primarily through private credit and real estate.

Singapore: The Monetary Authority of Singapore (MAS) uses a risk-based framework similar to Solvency II but with lower charges for private equity (25%) and private credit (4-6%). Singapore has become a hub for insurance-linked securities and alternative asset management.

Bermuda: The Bermuda Monetary Authority (BMA) uses a principles-based regime that is the most favorable for alternatives. Private equity charges are 15-20%, and the BMA has a dedicated "Long-Term Business" classification that allows insurers to hold illiquid assets with lower capital charges.

Rating Agency Impact#

Rating agencies—AMB Best, S&P, Moody's, and Fitch—apply their own capital models that often differ from regulatory frameworks. For US insurers, AMB Best's BCAR (Best's Capital Adequacy Ratio) is the most influential.

AMB Best has been increasingly skeptical of insurance allocations to private equity, particularly for life insurers. In 2024, AMB Best published a special report expressing concern about life insurers' growing exposure to private credit and private equity, noting that "the illiquidity premium earned may not adequately compensate for the liquidity risk assumed."

This has created a tension for insurance CIOs: regulatory capital charges are declining for alternatives, but rating agency scrutiny is increasing. GPs who can demonstrate how their fund reduces rating agency capital charges—through diversification, seniority, or credit enhancement—have a significant advantage.

Accounting Regimes: The Hidden Barrier to Insurance Allocations#

Regulatory capital is not the only constraint. Accounting treatment—specifically, how assets are classified on the balance sheet—determines whether an insurance company can tolerate the volatility of private market investments.

US GAAP vs. Statutory Accounting#

US insurers report under two accounting frameworks:

GAAP (Generally Accepted Accounting Principles): Used for public reporting and investor communications. Under GAAP, assets can be classified as:

• Trading: Marked to market through earnings (rare for insurers)
• Available-for-Sale (AFS): Marked to market through Other Comprehensive Income (OCI)
• Held-to-Maturity (HTM): Carried at amortized cost (rare for alternatives)

Statutory Accounting Principles (SAP): Used for regulatory reporting to state insurance departments. SAP is more conservative than GAAP and treats private market investments differently.

The critical distinction is that most private equity and private credit investments must be classified as AFS under GAAP, meaning they are marked to market through OCI. This introduces volatility to book value, which is a key metric for rating agencies and analysts.

For life insurers with long-dated liabilities, book value volatility is a primary concern. A 10% decline in private equity valuations can reduce book value by 2-3% for a life insurer with a 25% allocation to alternatives—a material impact that can trigger rating downgrades.

The "Shadow NAV" Problem#

Private market investments are not marked to market daily, but they are marked to market quarterly. This creates a "shadow NAV" problem: the reported book value of an insurer's private market portfolio lags public market movements, creating uncertainty about the true economic position.

Rating agencies and analysts have become more sophisticated in adjusting for this lag. AMB Best now requires insurers to disclose the "look-through" volatility of their private market portfolios, estimating what the NAV would be if it were marked to market daily using public market proxies.

GPs who can provide more frequent, more transparent NAV reporting—quarterly at minimum, with monthly estimates for large positions—are better positioned to attract insurance capital.

European IFRS 17#

European insurers adopted IFRS 17 in 2023, which fundamentally changed how insurance contracts are accounted for. IFRS 17 requires insurers to discount liabilities using current market rates, which has increased the sensitivity of reported earnings to interest rate movements.

The impact on alternatives allocations is indirect but significant. Under IFRS 17, insurers must hold assets that match the duration and cash flow characteristics of their liabilities. This favors private credit with predictable cash flows over private equity with uncertain cash flows.

European insurers have responded by increasing allocations to private credit and infrastructure debt, which provide the duration matching and cash flow predictability that IFRS 17 demands.

The Insurance Decision Chain: Who Decides and How#

The decision chain for insurance company LP commitments is longer and more complex than for any other LP category. GPs who understand this chain can navigate it effectively; those who don't will waste months on dead ends.

The Gatekeepers#

Chief Investment Officer (CIO): The CIO sets the strategic asset allocation and approves all material commitments. In large insurers ($50B+ AUM), the CIO is the ultimate decision-maker. In mid-sized insurers ($5-50B AUM), the CIO shares authority with an investment committee.

Head of Private Markets: Most insurers with $10B+ in alternatives have a dedicated private markets team. This team conducts initial due diligence, negotiates terms, and makes recommendations to the CIO. For smaller insurers, this function may be combined with the broader investment team.

Asset-Liability Management (ALM) Team: The ALM team is the unsung hero of insurance investing. They model the impact of every investment on liability coverage, duration matching, and cash flow adequacy. An investment that the CIO loves may be killed by the ALM team if it creates a duration mismatch.

Risk Management: The risk team calculates the impact of each investment on regulatory capital, rating agency capital, and economic capital. They are the internal skeptics, and their approval is required for any material commitment.

External Investment Consultant: Approximately 60% of US insurers and 70% of European insurers use an investment consultant for alternatives allocations. The consultant recommends asset allocation, conducts manager due diligence, and provides ongoing monitoring. GPs must win the consultant before they can win the insurer.

The Decision Process#

The typical decision process for a new fund commitment involves:

1. Initial Screening (2-4 weeks): The private markets team reviews the fund's strategy, track record, and team. If it passes initial criteria, it enters the "watch list."
2. Due Diligence (4-8 weeks): The team conducts detailed due diligence on investment strategy, operational infrastructure, legal structure, and ESG compliance. This includes reference calls with existing LPs.
3. Investment Committee (2-4 weeks): The private markets team presents a recommendation to the investment committee, which includes the CIO, risk team, and ALM team. The committee votes on approval.
4. Legal and Documentation (4-8 weeks): If approved, the legal team reviews the PPM, LPA, and side letter. This is where regulatory and accounting issues are resolved.
5. Funding (2-4 weeks): The insurer funds the commitment, typically within 30-60 days of signing.

The total timeline is 14-28 weeks from initial contact to funding. For first-time funds or emerging managers, the timeline can extend to 6-12 months.

The Veto Points#

There are five veto points in the insurance decision chain:

1. The Consultant: If the consultant does not approve the manager, the insurer will not invest. Consultants maintain approved lists of managers, and getting on these lists requires a separate diligence process.
2. The Risk Team: If the risk team determines that the investment creates excessive regulatory capital charges or rating agency concerns, it will be vetoed regardless of return potential.
3. The ALM Team: If the investment creates a duration mismatch or cash flow inadequacy, the ALM team will veto it.
4. The CIO: The CIO has final authority and can override any other veto point, but rarely does so for material commitments.
5. The Board: For commitments exceeding a certain threshold (typically $100-500M, depending on the insurer's size), board approval is required. Board members are often former regulators or rating agency analysts who are skeptical of alternatives.

Targeting Strategy for 2026: Where to Focus#

Not all insurance companies are created equal. The most efficient targeting strategy focuses on insurers with:

1. Existing alternatives allocations above 10%: These insurers have the infrastructure, expertise, and appetite for private markets. They are the easiest to convert.
2. Regulatory tailwinds: US insurers are benefiting from NAIC RBC reductions for private credit and infrastructure. European insurers will benefit from Solvency II reforms in 2026-2027.
3. Rating agency headroom: Insurers with strong capital positions (AMB Best A+ or higher) can absorb the capital charges of alternatives without rating pressure.
4. Growing liabilities: Life insurers with growing annuity books need yield-enhancing assets. P&C insurers with growing premium volumes need diversification.

Tier 1: The Largest Allocators#

These insurers have $10B+ in alternatives allocations and dedicated private markets teams:

United States:

• MetLife: $680B AUM, ~12% alternatives allocation. MetLife has separate allocations for private equity ($15B), private credit ($25B), real estate ($20B), and infrastructure ($10B). They invest directly and through funds.
• Prudential Financial: $480B AUM, ~14% alternatives. PGIM, their asset management arm, manages $50B+ in private markets. Prudential is a major allocator to private credit and real estate.
• AIG: $350B AUM, ~16% alternatives. AIG has been increasing private credit allocations as part of a portfolio restructuring.
• New York Life: $350B AUM, ~10% alternatives. New York Life is conservative but has been selectively increasing private credit and infrastructure.
• MassMutual: $250B AUM, ~12% alternatives. MassMutual has a growing private equity allocation through Barings, their asset management subsidiary.

Europe:

• Allianz: $1.2T AUM, ~8% alternatives. Allianz is the largest European insurer by AUM. They have dedicated allocations to private equity ($15B), private credit ($30B), infrastructure ($25B), and real estate ($20B).
• AXA: $800B AUM, ~10% alternatives. AXA IM manages $50B+ in private markets. AXA has been increasing infrastructure and private credit.
• Generali: $600B AUM, ~9% alternatives. Generali has a growing private markets allocation through their asset management subsidiary.
• Zurich Insurance: $400B AUM, ~12% alternatives. Zurich has been increasing private credit and infrastructure allocations.

Asia:

• Nippon Life: $600B AUM, ~6% alternatives. Nippon Life is conservative but has been increasing private credit allocations.
• China Life: $500B AUM, ~4% alternatives. China Life is constrained by the 5% cap on private equity but has been increasing private credit and real estate.
• Ping An: $450B AUM, ~8% alternatives. Ping An has the most sophisticated alternatives program among Chinese insurers.

Bermuda:

• Everest Re: $80B AUM, ~20% alternatives. Everest Re has a large private credit allocation.
• RenaissanceRe: $50B AUM, ~25% alternatives. RenaissanceRe invests in private equity and private credit through funds and direct co-investments.

Tier 2: Mid-Sized Insurers with Growing Appetite#

These insurers have $1-10B in alternatives allocations and are actively adding to their programs:

United States:

• Principal Financial: $200B AUM, ~8% alternatives. Principal has been increasing private credit allocations.
• Unum: $100B AUM, ~6% alternatives. Unum is conservative but has a growing private credit program.
• CNA Financial: $60B AUM, ~10% alternatives. CNA has a diversified alternatives program.
• Old Republic International: $40B AUM, ~8% alternatives. Old Republic has been increasing private credit.

Europe:

• Swiss Life: $200B AUM, ~10% alternatives. Swiss Life has a growing private markets allocation.
• Munich Re: $150B AUM, ~15% alternatives. Munich Re is a major reinsurer with significant alternatives exposure.
• SCOR: $80B AUM, ~12% alternatives. SCOR has been increasing private credit and infrastructure.

Asia:

• Dai-ichi Life: $200B AUM, ~5% alternatives. Dai-ichi is conservative but has been increasing private credit.
• Sompo Holdings: $100B AUM, ~7% alternatives. Sompo has a growing private equity program.

Tier 3: Emerging Insurers and Captives#

These are smaller insurers, captive insurance companies, and insurance-linked securities (ILS) managers that are increasingly active in alternatives:

• Captive insurers: Many corporations have captive insurance companies that invest in alternatives. These are often managed by OCIOs.
• ILS managers: Managers like Nephila, Twelve Capital, and Securis invest in insurance-linked securities and are increasingly allocating to private credit and private equity.
• Specialty insurers: Insurers focused on niche markets often have more flexible investment mandates.

The Pitch: What Insurance LPs Want to Hear#

The insurance LP pitch is different from any other LP pitch. Here is what to include:

The Regulatory Capital Section#

What to cover:

• How your fund's assets are classified under NAIC RBC or Solvency II
• The RBC charge your fund triggers (estimated)
• How your fund compares to peers on capital efficiency
• Any rating agency treatment (AMB Best, S&P)

Example language: "Our senior secured lending strategy qualifies as NAIC 1 under the new RBC methodology, with an estimated capital charge of 3.5%. This is 60% lower than the charge for a typical direct lending fund and 85% lower than a buyout fund."

The Accounting Section#

What to cover:

• How your fund is classified under GAAP/IFRS (AFS, HTM, etc.)
• The expected volatility of NAV and how it compares to public market proxies
• How your reporting cycle aligns with the insurer's reporting requirements
• Any liquidity management provisions

Example language: "We report NAV monthly with a 15-day lag. Our historical NAV volatility is 60% of the S&P 500, making our fund a low-volatility alternative to public equities for AFS classification."

The Liability Matching Section#

What to cover:

• The duration and cash flow profile of your fund
• How your fund matches the insurer's liability duration
• The yield enhancement relative to comparable public market assets
• Any stress testing under different interest rate scenarios

Example language: "Our infrastructure debt fund has a 12-year weighted average life and a 5.5% yield, providing a 200bps spread over 10-year Treasuries. The cash flows are predictable and match the duration of a typical life insurer's annuity liabilities."

The Due Diligence Section#

What to cover:

• Your track record and team experience
• Your operational infrastructure (fund administration, compliance, risk management)
• Your ESG framework and how it aligns with insurance regulatory requirements
• Your reference list (include insurance LPs if you have them)

Example language: "We have a 15-year track record in private credit with a 3.2% default rate and 85% recovery rate. Our team has managed insurance mandates for 10+ years, including a $500M mandate from a top-10 US life insurer."

Emerging Trends for 2026#

The Private Credit Boom#

Private credit is the single fastest-growing asset class for insurance companies. US insurance allocations to private credit grew from $150B in 2020 to an estimated $400B in 2025, and are projected to reach $600B by 2028.

The drivers are clear:

• Yield: Private credit offers 200-400bps spread over public credit
• Capital efficiency: Senior secured private credit has lower RBC charges than high-yield bonds
• Duration: Private credit can be structured to match liability duration
• Regulatory tailwinds: NAIC and Solvency II reforms favor private credit

The largest insurance private credit mandates include:

• MetLife: $25B+ in private credit
• Allianz: $30B+ in private credit
• AXA: $20B+ in private credit
• Prudential: $15B+ in private credit
• Zurich: $10B+ in private credit

Infrastructure and Energy Transition#

Infrastructure is the second-fastest-growing asset class for insurers. The energy transition creates enormous capital requirements, and insurers are natural providers of long-dated, stable-yield capital.

Key trends:

• Renewable energy: Solar, wind, and battery storage projects offer 10-20 year cash flows that match insurance liabilities
• Digital infrastructure: Data centers, fiber networks, and 5G infrastructure offer inflation-linked returns
• Transportation: Toll roads, airports, and ports offer regulated returns with low volatility
• Social infrastructure: Hospitals, schools, and housing offer government-backed cash flows

The RBC treatment for infrastructure is favorable: 1.5-3.0% for investment-grade infrastructure debt under US RBC, and 3.5-7.0% under Solvency II.

Co-Investment and Direct Investing#

Large insurers are increasingly co-investing alongside fund managers to reduce fees and gain direct exposure. This trend accelerated in 2024-2025 as insurers built internal private markets teams.

Insurers with active co-investment programs:

• MetLife: Co-invests in private credit and real estate
• Prudential: Co-invests in private equity and private credit
• Allianz: Co-invests in infrastructure and private credit
• AXA: Co-invests in real estate and private credit

GPs who can offer co-investment opportunities alongside their funds have a significant advantage in attracting insurance capital.

ESG and Regulatory Pressure#

ESG is not optional for insurance LPs. European insurers face mandatory ESG reporting under SFDR and the EU Taxonomy. US insurers are increasingly subject to state-level ESG requirements, particularly in New York, California, and Washington.

What insurance LPs want:

• Article 8 or 9 classification under SFDR (for European insurers)
• TCFD-aligned reporting on climate risk
• UN PRI signatory status
• Diversity metrics for fund management teams
• Impact reporting for infrastructure and energy transition funds

GPs who cannot provide ESG reporting will be excluded from insurance mandates in 2026.

Technology and Data#

Insurance companies are becoming more sophisticated in their use of data for investment decision-making. The Altss platform tracks 9,000+ family offices and 30,000+ institutional investors, including insurance companies, with sub-30-day refresh cycles on LP data.

For GPs targeting insurance capital, data is critical:

• Which insurers are actively allocating? The Altss platform tracks insurance LP activity, including recent commitments, target allocations, and decision timelines.
• Who are the decision-makers? The platform profiles CIOs, heads of private markets, and investment consultants.
• What are the regulatory constraints? The platform maps RBC charges, accounting treatment, and rating agency concerns for each insurer.

GPs who use data to target the right insurers with the right pitch will have a 3-5x higher conversion rate than those who use broad outreach.

The Altss Advantage#

The Altss platform provides the most comprehensive, continuously refreshed intelligence on insurance company LPs available anywhere. Our coverage includes:

• 9,000+ family offices and 30,000+ institutional investors, RIAs, and family offices
• 150,000+ private-markets entities mapped with relationship intelligence
• Sub-30-day refresh cycle on LP data, including insurance company allocations, regulatory changes, and decision-maker updates
• Institutional LP coverage live since February 2026, with dedicated insurance company profiles

For GPs raising capital in 2026, the insurance LP opportunity is too large to ignore—but too complex to approach without the right intelligence. The Altss platform provides the map, the data, and the insights to navigate this $30 trillion market.